These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 4347296

  • 1. Treatment of myasthenia gravis.
    Flacke W.
    N Engl J Med; 1973 Jan 04; 288(1):27-31. PubMed ID: 4347296
    [No Abstract] [Full Text] [Related]

  • 2. [Therapy of myasthenia gravis in pregnancy].
    Pezzoli G, Bonfadini Bossi E, Rella R.
    Minerva Ginecol; 1980 Jan 04; 32(1-2):21-6. PubMed ID: 6245392
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
    Riggs JE.
    Clin Neuropharmacol; 1982 Jan 04; 5(3):277-92. PubMed ID: 6288236
    [No Abstract] [Full Text] [Related]

  • 4. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K.
    Med Klin; 1973 Jun 01; 68(22):723-30. PubMed ID: 4715780
    [No Abstract] [Full Text] [Related]

  • 5. [On the treatment of myasthenia].
    Delwaide JP.
    Rev Med Liege; 1968 Sep 15; 23(18):552-7. PubMed ID: 4316587
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Current treatment of myasthenia gravis].
    de Assis JL.
    Rev Paul Med; 1965 Oct 15; 67(4):231-42. PubMed ID: 5848156
    [No Abstract] [Full Text] [Related]

  • 8. [Current therapy of myasthenia gravis. I. Specific symptomatic therapy].
    Erbslöh F.
    Nervenarzt; 1972 Jul 15; 43(7):341-4. PubMed ID: 4627866
    [No Abstract] [Full Text] [Related]

  • 9. [Application of germine alkaloid in myasthenia gravis. 2. Clinical application of germine monoacetate].
    Fukushima K, Toyama H.
    Nihon Rinsho; 1973 Feb 15; 31(2):336-40. PubMed ID: 4737115
    [No Abstract] [Full Text] [Related]

  • 10. [Current therapeutic aspects of myasthenia gravis].
    Avilés Mejias S, Ledro Molina D, Garrido Peralta M.
    Rev Clin Esp; 1981 Oct 31; 163(2):139-44. PubMed ID: 6276943
    [No Abstract] [Full Text] [Related]

  • 11. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J.
    Tidsskr Nor Laegeforen; 1971 Apr 20; 91(11):821-4. PubMed ID: 4326179
    [No Abstract] [Full Text] [Related]

  • 12. Veratrum alkaloids in the therapy of myasthenia gravis.
    Can Med Assoc J; 1967 Jun 10; 96(23):1534-5. PubMed ID: 6026341
    [No Abstract] [Full Text] [Related]

  • 13. [Therapies of myasthenia gravis (author's transl)].
    de Crousaz G.
    Schweiz Rundsch Med Prax; 1978 Jan 24; 67(4):113-7. PubMed ID: 202937
    [No Abstract] [Full Text] [Related]

  • 14. Veratrum and myasthenia gravis.
    Lancet; 1967 Jan 28; 1(7483):202-3. PubMed ID: 4163135
    [No Abstract] [Full Text] [Related]

  • 15. Single fibre EMG in juvenile myasthenia gravis.
    Stalberg E, Hansson O.
    Neuropadiatrie; 1973 Jan 28; 4(1):20-9. PubMed ID: 4349293
    [No Abstract] [Full Text] [Related]

  • 16. [Immunosuppressive therapy of myasthenia gravis].
    Lechner H, Ott E, Aranibar A.
    Nervenarzt; 1976 Jun 28; 47(6):353-6. PubMed ID: 183158
    [No Abstract] [Full Text] [Related]

  • 17. [Therapetic measures in myasthenia gravis].
    Cavaciuti P, Gatti E.
    Minerva Anestesiol; 1969 Aug 28; 35(8):765-79. PubMed ID: 5364124
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of myasthenia gravis with germine diacetate.
    Flacke W, Caviness VS, Samaha FG.
    N Engl J Med; 1966 Dec 01; 275(22):1207-14. PubMed ID: 5921854
    [No Abstract] [Full Text] [Related]

  • 19. Sites of action of gerine diacetate in myasthenia gravis.
    Flacke W, Caviness VS, Samaha F, Schwab RS.
    Trans Am Neurol Assoc; 1967 Dec 01; 92():158-62. PubMed ID: 5634017
    [No Abstract] [Full Text] [Related]

  • 20. Germine mono- and diacetate in myasthenia gravis.
    Flacke WE, Blume RP, Scott WR, Foldes FF, Osserman KE.
    Ann N Y Acad Sci; 1971 Sep 15; 183():316-33. PubMed ID: 5287830
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.